
A mutated H1N1 influenza strain is driving an unusually early and intense flu season across the United States. The Centers for Disease Control and Prevention reports that flu activity is currently elevated or actively growing in over 40 states. This surge has resulted in at least 1.7 million illnesses recorded so far this season. Influenza A is responsible for nearly all positive cases, with the A(H1N1)pdm09 subtype dominating the infections. The predominant H1N1 virus circulating this year carries a specific genetic mutation known as G155E. This alteration changes how the virus interacts with the human immune system. Researchers indicate this mutation may allow the virus to partially bypass the immune defenses built up from previous infections or older vaccinations. Epidemiologists note that teenagers and young adults under the age of 25 appear to have less residual immunity to this altered strain. The rapid accumulation of cases occurred early in the season before many individuals could receive their annual vaccinations. Despite this genetic shift, early clinical data suggests there is no evidence that the G155E mutation causes more severe illness than previous iterations of the virus. Health officials confirm that the current seasonal flu vaccine still recognizes the circulating mutated virus and provides substantial protection against it. Immunologists emphasize that while the virus has adapted, the vaccine remains a critical tool for preventing severe respiratory complications and hospitalization. Taking standard preventive measures remains highly effective in slowing the spread of this seasonal outbreak. Multiple Sources: Centers for Disease Control and Prevention, "Weekly US Influenza Surveillance Report: Key Updates for Week 44," FluView, November 13, 2026 Health and Me, "US Flu Cases Rising: What To Know About The New G155E H1N1 Mutation," November 10, 2026.
















